We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.02B
AUM Growth
+$74.7M
Cap. Flow
-$986K
Cap. Flow %
-0.1%
Top 10 Hldgs %
31.61%
Holding
254
New
10
Increased
66
Reduced
77
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$1.65M
3
BX icon
Blackstone
BX
+$1.52M
4
DIS icon
Walt Disney
DIS
+$869K
5
ZTS icon
Zoetis
ZTS
+$790K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.24M
2
BA icon
Boeing
BA
+$1.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.35M
4
XOM icon
ExxonMobil
XOM
+$1.3M
5
AGN
Allergan plc
AGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 16.35%
3 Financials 15.15%
4 Industrials 12.69%
5 Energy 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
201
Cardinal Health
CAH
$55.4B
$227K 0.02%
4,482
-150
-3% -$7.75K
WTM icon
202
White Mountains Insurance
WTM
$5.13B
$223K 0.02%
200
– –
MER.PRK
203
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$216K 0.02%
8,000
– –
WBA
204
DELISTED
Walgreens Boots Alliance
WBA
$215K 0.02%
3,644
– –
LOW icon
205
Lowe's Companies
LOW
$125B
$214K 0.02%
+1,786
New +$204K
HWC icon
206
Hancock Whitney
HWC
$6.24B
$213K 0.02%
+4,850
New +$197K
BKNG icon
207
Booking.com
BKNG
$161B
$205K 0.02%
+2,500
New +$196K
CHD icon
208
Church & Dwight Co
CHD
$24.5B
$205K 0.02%
2,920
– –
BLK icon
209
Blackrock
BLK
$176B
$201K 0.02%
+400
New +$190K
NRT
210
North European Oil Royalty Trust
NRT
$81M
$165K 0.02%
27,999
– –
NTRP
211
DELISTED
Neurotrope, Inc. Common
NTRP
$107K 0.01%
109,375
– –
MRKR icon
212
Marker Therapeutics
MRKR
$18.7M
$87K 0.01%
3,010
– –
WHWK
213
Whitehawk Therapeutics
WHWK
$271M
$62K 0.01%
6,667
– –
XCUR icon
214
Exicure
XCUR
$8.54M
$48K ﹤0.01%
111
– –
MTNB icon
215
Matinas BioPharma
MTNB
$1.81M
$40K ﹤0.01%
350
– –
HSY icon
216
Hershey
HSY
$36.6B
– –
-1,300
Closed -$201K
OXY icon
217
Occidental Petroleum
OXY
$55.9B
– –
-11,277
Closed -$501K
CELG
218
DELISTED
Celgene Corp
CELG
– –
-93,069
Closed -$9.24M
5 6 7 8
9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, Neville Rodie & Shaw held 254 positions worth $1.02B, up 7.9% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Neville Rodie & Shaw's Q4 2019 filing shows 10 new, 66 increased, 77 reduced and 4 closed positions. Its largest new stake was Qualcomm: 19,730 shares worth $1.74M. The largest sale was Celgene Corp, an estimated $9.24M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q4 2019 buy was Qualcomm: 19,730 shares worth $1.74M.
  • Neville Rodie & Shaw added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.43M increase.
  • Neville Rodie & Shaw's biggest Q4 2019 reduction was Boeing, cutting an estimated $1.45M.
  • Neville Rodie & Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $9.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 32% of its $1.02B portfolio in Q4 2019.
  • Neville Rodie & Shaw opened 10 new positions and closed 4 in Q4 2019.
  • Neville Rodie & Shaw's portfolio value rose 7.9% quarter-over-quarter to $1.02B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.